The importance of patient engagement in the management of giant cell arteritis
Giant cell arteritis (GCA) is a vascular condition characterized by ocular, systemic and neurological symptoms. Visual loss is the dreaded complication of this condition, prompting expedient diagnosis and treatment. Treatment typically involves prolonged glucocorticoid therapy which is often accompa...
Main Authors: | Nikhil Patil, Max Gelkopf, Santano Rodrigues, Arun Sundaram |
---|---|
Format: | Article |
Language: | English |
Published: |
The Beryl Institute
2022-11-01
|
Series: | Patient Experience Journal |
Subjects: | |
Online Access: | https://pxjournal.org/journal/vol9/iss3/5 |
Similar Items
-
Biologic Therapies for Giant Cell Arteritis
by: Harrington R, et al.
Published: (2021-01-01) -
A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis
by: Hoon E, et al.
Published: (2019-08-01) -
Giant cell arteritis: a multicenter observational study in Brazil
by: Alexandre Wagner Silva de Souza, et al.
Published: (2013-01-01) -
Giant cell arteritis. Part II. Treatment
by: Azamat Makhmudovich Satybaldyev
Published: (2012-12-01) -
Giant Cell Arteritis
by: Bruno Coulier, et al.
Published: (2018-01-01)